LBRX
LB PHARMACEUTICALS INC
Nasdaq Pharmaceutical Preparations
Emerging growth company

Key Financials

Net Income
$-25205000
↑ 60.1%
Total Liabilities
$11.6M
↓ 15.9%
Shareholders' Equity
$301.3M
↑ 418.7%
Total Assets
$312.9M
↑ 833.2%
EPS (Diluted)
$-3.13
↑ 98.2%
Cash & Equivalents
$250.2M
↑ 988.8%
Operating Cash Flow
$-35208000.00
↑ 33.6%

Recent SEC Filings

Form Type Filed Date Link
POS AM 10/1/2026 View on SEC
S-3ASR 10/1/2026 View on SEC
3 9/24/2026 View on SEC
424B3 9/15/2026 View on SEC
8-K 9/15/2026 View on SEC
3 9/14/2026 View on SEC
424B3 9/3/2026 View on SEC
8-K 9/3/2026 View on SEC
SCHEDULE 13G/A 8/14/2026 View on SEC
424B3 8/11/2026 View on SEC

Company Information

Field Value
Ticker LBRX
Company Name LB PHARMACEUTICALS INC
CIK 1691082
Sector Pharmaceutical Preparations
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 917-450-6581